Fernando Mezzomo, CEO of Antidote, Announces their Platform Launch with Closed Community X on It
November 23, 2023 07:51 ET | Antidote
NEW YORK, NY, Nov. 23, 2023 (GLOBE NEWSWIRE) -- Today, Antidote founder and CEO Fernando Mezzomo unveiles the closed community "X", designed to give people equal access to profitable investment...
BTG Pharmaceuticals,
BTG Pharmaceuticals, a SERB company, to present data on ricin antidote development programme at the North American Congress of Clinical Toxicology
September 21, 2023 06:42 ET | BTG Specialty Pharmaceuticals
West Conshohocken, PA, Sept. 21, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, announced today that SERB will present in vivo data for PR022, a polyclonal antibody in development as...
IRB Logo.png
Global Antidote Market Size and Share 2022 | Covid-19 Impact Analysis by Sales Revenue, Future Demands, Growth Factors and Drivers, Emerging Trends, Competitive Landscape and Forecast to 2027
March 28, 2022 03:19 ET | Industry Research
Pune, March 28, 2022 (GLOBE NEWSWIRE) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Antidote Market” Research Report 2022-2027 is a historical overview...
InspireLogo_Together_July2016.jpg
Inspire and Antidote Launch End-to-End Clinical Trial Recruitment Solution to Accelerate Medical Research
January 04, 2018 07:00 ET | Inspire
ARLINGTON, Va. and NEW YORK, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Inspire, the leading healthcare social network, and Antidote, a digital health company that connects patients with research, announced...